Outlook on Developing Drugs

Outlook on Developing Drugs

Kamada: Announces New Data on Glassia

Kamada a biopharmaceutical firm involved in developing and marketing drugs which are of human benefit using protein purification technology. Now again Kamada has come up with a drug Glassia containing AAT protein which shows therapeutic properties Read more…

Be the first to comment - What do you think?
Posted by Samantha Adams - 28/11/2012 at 05:41

Categories: Medical, Outlook on Developing Drugs, Pharmaceutical Sciences   Tags: , ,

Antiviral Drugs: An Approach to Abate Liver Cancer

Hepatitis C a very common chronic infection which is an indirect cause of disease that most of the US population is fighting with i.e. the cancer. According to the Centres for Disease Control and Prevention (CDC), 3.2 million Americans are Read more…

Be the first to comment - What do you think?
Posted by Samantha Adams - 05/11/2012 at 06:05

Categories: Medical, Outlook on Developing Drugs, Pharmaceutical Sciences   Tags: , ,

Mild Alcoholism: Diminishes Brain Cells

Rutgers University study indicates that there is a fine line between moderate and binge drinking that can decrease the number of new brain cells by as much as 40 percent.When moderate drinking becomes the binge drinking structural integrity of the Read more…

Be the first to comment - What do you think?
Posted by Selina - 03/11/2012 at 02:34

Categories: Medical, Outlook on Developing Drugs, Pharmaceutical Sciences   Tags: ,

Cholesterol: Riot to Healthy Living

Cholesterol the word heard many times, everyone recommends control intake of cholesterol. But nobody truly knows its side effect on the body. Approximately one in every six adults—17% of the U.S. adult population—has high blood cholesterol. Read more…

Be the first to comment - What do you think?
Posted by Samantha Adams - 17/10/2012 at 02:40

Categories: Medical, Outlook on Developing Drugs, Pharmaceutical Sciences   Tags: , ,

Kenya & Killi’s Reviews: Epilepsy Treatment Associated with Risk Factors

It has been reviewed through cross- sectional study that epilepsy treatment has been associated with several risk factors due to gaps in biomedical treatments. Low-income countries previews showed that many people with epilepsy do not receive appropriate biomedical treatment; Read more…

Be the first to comment - What do you think?
Posted by Samantha Adams - 06/09/2012 at 04:46

Categories: Medical, Outlook on Developing Drugs, Pharmaceutical Sciences   Tags: , ,